Open access
Oct 2026
Laminarin suppresses PD-L1 translation by targeting YTHDF1 to exert antitumor immunity in triple-negative breast cancer.
Triple-negative breast cancer (TNBC) is characterized by low response rates and rapid acquired resistance to current immunotherapies, highlighting an urgent unmet clinical need for novel therapeutic strategies. Herein, we demonstrated that laminarin, a biocompatible β-1,3-glucan extracted from brown algae, exerts signi...
Fangning Lou, Xiao-Ya Zhang, J. Fu et al.
· Pharmacological Research · 0 citations